Atopic diseases and oncopathology. What do they have in common? A review
- Authors: Ustimenko V.I.1, Logvinenko N.I.1
-
Affiliations:
- Novosibirsk State Medical University
- Issue: Vol 24, No 12 (2022)
- Pages: 894-898
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/144229
- DOI: https://doi.org/10.26442/20751753.2022.12.201949
- ID: 144229
Cite item
Full Text
Abstract
The increasing prevalence of cancer worldwide has influenced the interest of researchers to search for factors that may trigger oncogenesis in order to prevent and treat cancer. There is a burning question, can allergic diseases cause or prevent cancer? Numerous epidemiological studies have been conducted that have evaluated aspects of the relationship between allergic diseases and the occurrence of cancers of various localizations. The results of most of these studies are inconsistent, both in the nature of the course of the disease and in the variety of localizations of the occurrence of cancer. In this connection, two basic theories were suggested: the theory of immune surveillance and the theory of inflammation. This review analyzed current scientific work to estimate the incidence of neoplasms against the background of atopic diseases. The analysis of clinical studies shows inconsistent results of the association between allergic diseases and cancer. Several studies an inverse relationship between atopic diseases and cancer risk, which supports the theory of immune surveillance [brain tumor (glioma), pancreatic cancer, colorectal cancer, non-Hodgkin's lymphoma, and breast cancer, cancer of the mouth and throat, larynx]. At the same time, a number of studies note a positive association between atopic diseases and cancer, which confirms the theory of chronic inflammation (lung cancer and colorectal cancer combined with bronchial asthma). The lack of an unequivocal explanation testifies to the urgency of long-term prospective studies aimed at studying the risk factors of cancer in combination with atopic diseases with the subsequent development of risk scale for the purpose of patient stratification, screening, development of early detection programs and new approaches to the treatment of malignant neoplasms.
Full Text
##article.viewOnOriginalSite##About the authors
Valeriya I. Ustimenko
Novosibirsk State Medical University
Author for correspondence.
Email: valeriya.slesarenko@inbox.ru
ORCID iD: 0000-0002-3959-9001
Graduate Student, Novosibirsk State Medical University
Russian Federation, NovosibirskNadezhda I. Logvinenko
Novosibirsk State Medical University
Email: nadejda-logvinenko@yandex.ru
ORCID iD: 0000-0003-3091-0593
SPIN-code: 4735-9667
D. Sci. (Med.), Novosibirsk State Medical University
Russian Federation, NovosibirskReferences
- Chang VC, Cotterchio M, De P, Tinmouth J. Risk factors for early-onset colorectal cancer: a population-based case-control study in Ontario, Canada. Cancer Causes Control. 2021;32(10):1063-83. doi: 10.1007/s10552-021-01456-8
- Kozłowska R, Bożek A, Jarząb J. Association between cancer and allergies. Allergy, Asthma Clin Immunol. 2016;12(1):39. doi: 10.1186/s13223-016-0147-8
- Пампура А.Н. Проблемы и перспективы развития детской аллергологии. Российский вестник перинатологии и педиатрии. 2015;60(1):7-15 [Pampura AN. Development of pediatric allergology: Problems and prospects. Russian Bulletin of Perinatology and Pediatrics. 2015;60(1):7-15 (in Russian)].
- Carneiro BGMC, Petroianu A, Machado JAN, et al. Clinical and immunological allergy assessment in cancer patients. Sci Rep. 2021;11(1):18110. doi: 10.1038/s41598-021-97200-y
- McCraw AJ, Chauhan J, Bax HJ, et al. Insights from IgE immune surveillance in allergy and cancer for anti-tumour IgE treatments. Cancers (Basel). 2021;13(17):4460. doi: 10.3390/cancers13174460
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. doi: 10.3322/caac.21660
- Schwartzbaum J, Ding B, Johannesen TB, et al. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst. 2012;104(16):1251-9. doi: 10.1093/jnci/djs315
- Ma W, Yang J, Li P, et al. Association between allergic conditions and colorectal cancer risk/mortality: a meta-analysis of prospective studies. SciRep. 2017;7(1):5589. doi: 10.1038/s41598-017-04772-9
- Tambe NA, Wilkens LR, Wan P, et al. Atopic allergic conditions and colorectal cancer risk in the Multiethnic Cohort Study. Am J Epidemiol. 2015;181(11):889-97. doi: 10.1093/aje/kwu361
- Engkilde K, Thyssen JP, Menné T, Johansen JD. Association between cancer and contact allergy: a linkage study. BMJ Open. 2011;1(1):e000084. doi: 10.1136/bmjopen-2011-000084
- Turner MC, Chen Y, Krewski D, et al. Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol. 2005;162(3):212-21. doi: 10.1093/aje/kwi193
- Chou WY, Lai PY, Hu JM, et al. Association between atopic dermatitis and colorectal cancer risk: A nationwide cohort study. Medicine (Baltimore). 2020;99(1):e18530. doi: 10.1097/MD.0000000000018530
- Ye J, Talaiti A, Ma Y, et al. Allergies and risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Oncotarget. 2017;8(9):14646-54. doi: 10.18632/oncotarget.14599
- Rava M, Czachorowski MJ, Silverman D, et al. Asthma status is associated with decreased risk of aggressive urothelial bladder cancer. Int J Cancer. 2018;142(3):470-6. doi: 10.1002/ijc.31066
- Turner MC, Chen Y, Krewski D, Ghadirian P. An overview of the association between allergy and cancer. Int J Cancer. 2006;118(12):3124-32. doi: 10.1002/ijc.21752
- Michaud DS, Langevin SM, Eliot M, et al. Allergies and risk of head and neck cancer. Cancer Causes Control. 2012;23(8):1317-22. doi: 10.1007/s10552-012-0009-8
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30. doi: 10.3322/caac.21590
- Huang BZ, Le Marchand L, Haiman CA, et al. Atopic allergic conditions and pancreatic cancer risk: Results from the Multiethnic Cohort Study. Int J Cancer. 2018;142(10):2019-27. doi: 10.1002/ijc.31241
- Wang G, Xu Z, Zhu J, et al. Decreased risk in the pancreatic cancer with history of hay fever: A meta-analysis. Front Public Heal. 2020;8(1):7-30. doi: 10.3389/fpubh.2020.551490
- Cotterchio M, Lowcock E, Hudson TJ, et al. Association between allergies and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(3):469-80. doi: 10.1158/1055-9965.EPI-13-0965
- Zhu J, Song J, Liu Z, et al. Association between allergic conditions and risk of prostate cancer: A prisma-compliant systematic review and meta-analysis. Sci Rep. 2016;6(1):35682. doi: 10.1038/srep35682
- Wang H, Rothenbacher D, Löw M, et al. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer. 2006;119(3):695-701. doi: 10.1002/ijc.21883
- Vojtechova P, Martin RM. The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis. Cancer Causes Control. 2009;20(7):1091-105. doi: 10.1007/s10552-009-9334-y
- Qu YL, Liu J, Zhang LX, et al. Asthma and the risk of lung cancer: a meta-analysis. Oncotarget. 2017;8(7):11614-20. doi: 10.18632/oncotarget.14595
- Rosenberger A, Bickeböller H, McCormack V, et al. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis. 2012;33(3):587-97. doi: 10.1093/carcin/bgr307
- Jiang L, Sun YQ, Langhammer A, et al. Asthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study. Sci Rep. 2021;11(1):4539. doi: 10.1038/s41598-021-84012-3
- Kantor ED, Hsu M, Du M, Signorello LB. Allergies and asthma in relation to cancer risk. Cancer Epidemiol Biomarkers Prev. 2019;28(8):1395-403. doi: 10.1158/1055-9965.EPI-18-1330
- Santillan AA, Camargo CA Jr, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control. 2003;14(4):327-34. doi: 10.1023/a:1023982402137
- Rosenberger A, Bickeböller H, McCormack V, et al. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis. 2012;33(3):587-97. doi: 10.1093/carcin/bgr307
- Bożek A, Jarzab J, Mielnik M, et al. Can atopy have a protective effect against cancer? PLoS One. 2020;15(2):e0226950. doi: 10.1371/journal.pone.0226950
- Vajdic CM, Falster MO, de Sanjose S, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 2009;69(16):6482-9. doi: 10.1158/0008-5472.CAN-08-4372
- Mansfield KE, Schmidt SAJ, Darvalics B, et al. Association between atopic eczema and cancer in England and Denmark. JAMA Dermatol. 2020;156(10):1086-97. doi: 10.1001/jamadermatol.2020.1948
- Linabery AM, Prizment AE, Anderson KE, et al. Allergic diseases and risk of hematopoietic malignancies in a cohort of postmenopausal women: a report from the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2014;23(9):1903-12. doi: 10.1158/1055-9965.EPI-14-0423
Supplementary files
